SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-040984
Filing Date
2017-08-08
Accepted
2017-08-08 06:05:47
Documents
2
Period of Report
2017-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v472635_8k.htm 8-K 15915
2 EXHIBIT 99.1 v472635_ex99-1.htm EX-99.1 90071
  Complete submission text file 0001144204-17-040984.txt   107136
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 171013134
SIC: 2834 Pharmaceutical Preparations